VAD protocol

chemotherapy protocol consisting of above cpds; used in treatment of rhabdomyosarcoma in children

Networked: 5 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - VAD protocol: 5
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - VAD protocol: 5
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - VAD protocol: 5
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        VAD protocol: 5
- Fused-Ring Compounds
  - Steroids: 70059
    - Fluorinated Steroids: 32
      - Dexamethasone: 23151
        VAD protocol: 5
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienetriols
        Dexamethasone: 23151
        VAD protocol: 5
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthacenes
        Anthracyclines: 9423
        Daunorubicin: 2641
        Doxorubicin: 35390
        VAD protocol: 5
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        VAD protocol: 5
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Indole Alkaloids: 200
    - Secologanin Tryptamine Alkaloids: 81
      - Vinca Alkaloids: 463
        Vincristine: 9251
        VAD protocol: 5
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vincristine: 9251
        VAD protocol: 5
    - Indolizines: 3
      - Indolizidines: 2
        Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vincristine: 9251
        VAD protocol: 5

Experts

1.	Dokekias, Alexis Elira: 1 article (07/2011)
2.	Andreeva, N E: 1 article (01/2003)
3.	Kozlovskaia, L V: 1 article (01/2003)
4.	Rameev, V V: 1 article (01/2003)
5.	Sarkisova, I A: 1 article (01/2003)
6.	Aydogdu, I: 1 article (12/2000)
7.	Kaya, E: 1 article (12/2000)
8.	Kuku, I: 1 article (12/2000)
9.	Ozturan, O: 1 article (12/2000)
10.	Sevinc, A: 1 article (12/2000)

Related Diseases

1.	Multiple Myeloma 09/01/1987 - "Evaluation of survival for responders (15 mos) versus non-responders (2 mos) by the landmark method seems to confirm the relative therapeutic efficacy of the VAD protocol in refractory multiple myeloma. " 07/01/2011 - "[Could the VAD protocol be the first line therapy for multiple myeloma in subSaharan Africa? " 09/01/1987 - "VAD protocol for treatment of advanced refractory multiple myeloma." 01/01/2003 - "[Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol]."
2.	Immunoglobulin Light-chain Amyloidosis 01/01/2003 - "[Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol]."
3.	Stroke (Strokes) 01/01/2023 - "Development of a VAD protocol decreased time to imaging for suspected stroke and reduced unnecessary imaging. "
4.	Sudden Hearing Loss (Sudden Deafness) 12/01/2000 - "Sudden hearing loss associated with vincristine therapy is a rarely observed event in the VAD protocol. "

Related Drugs and Biologics

1.	Vincristine (Oncovin)

Related Therapies and Procedures

1.	Therapeutics